159 results
Page 4 of 8
8-K
EX-99.1
7zhzqeaq9x l06r
28 Jan 20
Other Events
4:35pm
8-K
EX-99.2
dw3wbe3udnz7zm
28 Jan 20
Other Events
4:35pm
8-K
EX-99.1
7au0majjmtensyjuo
6 Jan 20
Dyadic Reports Continued Positive Business Trends and Scientific Results in Fourth Quarter 2019
4:25pm
8-K
EX-99.1
482r 9k61
5 Jul 19
Dyadic Extends Research and Development Agreement with VTT
3:55pm
8-K
EX-99.1
olt3n1dgaq
27 Jun 19
Dyadic Announces Appointment of Ping Rawson to CFO
4:37pm
8-K
EX-99.1
u0o1iz0w7e6su5
9 May 19
Dyadic Reports First Quarter Financial Results and Recent Developments
4:13pm
10-Q
bg5qcxzn3 oa4d4
9 May 19
Quarterly report
4:11pm
8-K
EX-99.1
ljvh 71b2ld
8 May 19
Dyadic andĀ Serum InstituteĀ of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products and Vaccines
4:26pm
8-K
EX-99.1
fan6is7i9 2x7z
8 May 19
Dyadic Announces Sub-Licensing Agreement with Alphazyme
3:15pm
8-K
EX-99.1
ir56v
2 May 19
Dyadic Announces Sub-Licensing Agreement with Luina Bio
4:05pm
8-K
EX-10.2
z1b vw8q7
2 May 19
Dyadic Announces Sub-Licensing Agreement with Luina Bio
4:05pm
8-K
EX-99.1
13podvby
15 Apr 19
Dyadic Announces Uplisting to the Nasdaq Capital Market
11:08am
8-K
EX-99.1
mg9fwwm99ai013lshgf
27 Mar 19
Dyadic Reports 2018 Year End Results and Recent Developments
4:32pm
10-K
wk7 axh2hrhl0
27 Mar 19
Annual report
4:30pm
8-K
EX-99.1
irwnl6mfs8pf f8r5l
13 Feb 19
Dyadic Announces Effectiveness of Form 10
12:17pm
10-12G/A
wdwld
8 Feb 19
Registration of securities (amended)
5:26pm
10-12G
EX-10.1
j2eld
14 Jan 19
Registration of securities
5:23pm